Polen Capital Management
MIRM icon

Polen Capital Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Polen Capital Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.45M Buy
20,899
+368
+2% +$36.9K 0.02% 112
2026
Q1 		$1.9M Buy
20,531
+7,171
+54% +$675K 0.01% 104
2025
Q4 		$1.06M Buy
13,360
+21
+0.2% +$1.51K ﹤0.01% 132
2025
Q3 		$978K Sell
13,339
-2,168
-14% -$138K ﹤0.01% 143
2025
Q2 		$789K Buy
+15,507
New +$690K ﹤0.01% 159

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Polen Capital Management's MIRM Position: Q2 2026 in Review

Polen Capital Management increased its Mirum Pharmaceuticals (MIRM) stake by 1.8% in Q2 2026, buying an estimated $36.9K and bringing the position to 20,899 shares worth $2.45M. The position accounts for 0.02% of the portfolio, ranked #112.

Polen Capital Management first reported a position in MIRM in Q2 2025 and has held it in 5 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Polen Capital Management held 20,899 shares of Mirum Pharmaceuticals worth $2.45M as of Q2 2026.
  • Polen Capital Management bought 368 Mirum Pharmaceuticals shares in Q2 2026, an estimated $36.9K.
  • Mirum Pharmaceuticals made up 0.02% of Polen Capital Management's portfolio in Q2 2026, its #112 holding.
  • Polen Capital Management first reported a position in Mirum Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Polen Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.